期刊文献+

卵巢交界性肿瘤的临床特征及诊治进展 被引量:9

Clinical characteristics and research progress of diagnosis and treatment of borderline ovarian tumors
下载PDF
导出
摘要 交界性卵巢肿瘤生物学行为介于良性与恶性肿瘤之间,具有核异型性、核分裂象,但无间质浸润。手术切除是治疗交界性卵巢肿瘤的主要方法,但由于多发生于生育年龄妇女,且诊断常发生在术中,缺乏确切的术前诊断标准,而且多数患者都要求保留生育能力,因此交界性卵巢肿瘤的早期诊断、保守性治疗、术后化疗、术后生育功能都存在着争议。本文对近年来卵巢交界性肿瘤临床特征、诊断及治疗进行综述。 The biological behavior of borderline ovarian tumors( BOTs)is between benign neoplasm and malignant tumor,with nuclear atypia,fission phase,but without the interstitial infiltration. Surgical removal is the main manage-ment. Clinically,BOTs occur in women in the reproduction age group. Due to the absence of specific preoperative cri-teria,diagnosis is often made during surgery,and majority of the young woman patients want to preserve their child bearing potential. Thus,a lot of debate exists on the early diagnosis,conservative surgery,postoperative chemotherapy and fertility out-come. The article will review the clinical characteristics,diagnosis and treatment of BOTs.
作者 陈慧 王晶
出处 《现代肿瘤医学》 CAS 2015年第17期2525-2528,共4页 Journal of Modern Oncology
关键词 卵巢 交界性肿瘤 诊断 治疗 ovarian borderline tumors diagnosis treatment
  • 相关文献

参考文献3

二级参考文献32

  • 1戴晴,刘真真,姜玉新,杨佳欣,吕珂,冷金花,高嫔.经阴道超声造影在附件包块诊断中的应用研究[J].中华超声影像学杂志,2006,15(9):693-697. 被引量:37
  • 2Vandenput I, Amant F, Vergote I. Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy [ J ]. Gynecol Oncol, 2005, 98 ( 3 ): 523-525. 被引量:1
  • 3Fortin A, Mofice P, Thoury A, et al. Impact of infertility drugs after treatment of borderline ovarian tumors:Resuhs of a retrospective muhicenter study [J ]. Fertil Steril, 2007, 87 (3): 591-596. 被引量:1
  • 4Park CW, Yang KM, Kim HO, et al. Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment [J]. J Korean Med Sci, 2007, 22 (Suppl): 134-138. 被引量:1
  • 5Olszewska H, Stukan M, Emerich J. Clinical analysis of patients with recurrences of borderline ovarian tumors including surgical treatment [J]. Ginekol Pol, 2005, 76( 10): 782-787. 被引量:1
  • 6Yokoyama Y, Moriya T, Takano T, et al. Clinical outcome and risk factors for recurrence in borderline ovarian turnouts [J ]. Br J Cancer, 2006, 94( 11 ): 1586-1591. 被引量:1
  • 7Vrabie CD, Petrescu A, Waller M, et al. Clinical factors and biomarkers in ovarian tumors development[J]. Rom J Morphol Embryol, 2008, 49(3 ): 327-338. 被引量:1
  • 8Ayhan A, Guven S, Guven ES, et al. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? [J]. Acta Obstet Gynecol Scand, 2007, 86 (4): 484-490. 被引量:1
  • 9Van Calster B, Timmerman D, Bourne T, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125 [J]. J Natl Cancer Inst, 2007, 99(22): 1706-1714. 被引量:1
  • 10Maheshwari A, Gupta S, Kane S, et al. Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: experience at a tertiary ontology center[J]. World J Surg Oncol, 2006, 4: 12. 被引量:1

共引文献17

同被引文献66

  • 1Jing Lu,Xiao-Feng Li,Li-Xia Kong,Lin Ma,Su-Huan Liao,Chang-You Jiang.Expression and significance of cyclooxygenase-2 mRNA in benign and malignant ascites[J].World Journal of Gastroenterology,2013,19(40):6883-6887. 被引量:12
  • 2李艺,祝洪澜,崔恒,魏丽惠.青少年卵巢肿瘤的临床病理分析[J].实用妇产科杂志,2005,21(10):601-604. 被引量:16
  • 3Mikami Y. Paradigm shift in ovarian tumor pathology from the view ofgenomic abnormalities [J]. Gan To Kagaku Ryoho, 2016,43(3) :286-289. 被引量:1
  • 4孙但窈.卵巢交界性肿瘤病理及影响预后相关因素分析[D],乌鲁木齐:新疆医科大学.2015. 被引量:1
  • 5Hashmi AA, Hussain ZF,Bhagwani AR,et al. Clinico- pathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors:an institutional perspective [J]. BMC Res Notes, 2016,9(1) : 205. 被引量:1
  • 6Li X, Yang J,Wang X, et al. Role of TWIST2, E -cad- herin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression [J]. Eur J Gynaecol Oncol, 2016,37(1 ) : 100-108. 被引量:1
  • 7Tiwari RK, Saha K, Mukhopadhyay D, et al. Evaluation of preoperative serum levels of CA125 and Expression of p53 in ovarian neoplasms:a prospective clinicopathologi- cal study in a Tertiary Care Hospital [J]. J Obstet Gynaeeol India, 2016,66(2) : 107-114. 被引量:1
  • 8Yoshida A, Derchain SF,Pitta DR,et al. Comparing the Copenhagen Index (CPH-I)and Risk of Ovarian Malig- nancy Algorithm(ROMA) :two equivalent ways to differ- entiate malignant from benign ovarian tumors before surgery? [J]. Gynecol Oncol,2016,140(3) :481-485. 被引量:1
  • 9马娟,赵卫东.交界性卵巢肿瘤的诊治进展[J].国际妇产科学杂志,2009,36(4):283-286. 被引量:3
  • 10宋晓翠,滕洪涛,张建海,殷红梅,余江,田向文.联合检测血清HE4和CA125在卵巢癌早期诊断及病情监测中的价值[J].实用医学杂志,2012,28(14):2380-2382. 被引量:71

引证文献9

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部